Episode
GLP-1s in MCAS with Dr. Tania Dempsey
- Published
- May 30, 2026
- Duration seconds
- 2511
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/mast-cell-matters-deep-dives-on-mcas-with-tania-dempsey-md-presented-by-the-potscast-6696080/episodes/glp-1s-in-mcas-with-dr-tania-dempsey/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/mast-cell-matters-deep-dives-on-mcas-with-tania-dempsey-md-presented-by-the-potscast-6696080/glp-1s-in-mcas-with-dr-tania-dempsey.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This is a not-to-be-missed episode! Dr. Dempsey discusses the use of GLP-1 medications for MCAS, including her most recent observations and recommendations. This is a follow-up to Dr. Dempsey's free online GLP-1 Masterclass, which covers all the basics. If you have questions for Dr. Dempsey about mast cells and related topics, you can send them to [email protected]. Dr. Dempsey's published article about GLP-1 treatments in MCAS is here. Dr. Dempsey's website is https://drtaniadempsey.com/ If you liked this episode, we hope you will click subscribe so that you don't miss an episode. If you are so moved, donations are accepted to help to support our production costs https://www.standinguptopots.org/donate Tell us what you think of The POTScast or send us your idea at [email protected]! Find out more about Standing Up to POTS! Check us out on our Website: www.standinguptopots.org Facebook: https://www.facebook.com/standinguptopots/ Instagram: https://www.instagram.com/standinguptopots/ X: https://twitter.com/POTSActivist Medical Disclaimer: The information provided here is not intended to serve as professional medical advice, diagnosis, or treatment. If you have health related issues, please contact a qualified health professional to get the personalized assessment, advice, and treatment that you need. Standing Up to POTS will not be liable for any direct, indirect, or other damages arising from the use of this podcast.